DIAGEN AS
Score · fiscal year 2025
37of 100
How to read this: the company is ahead of 29 % of small companies in the same sector in 2025. What does this mean?
Rank: 28,084 of 38,670 · Handel
Profile
Beaver · Builder
Lower profitability, lower solidity
Position against comparable companies in 2025, not a verdict on the company. Based on profitability 29 and solidity 25 out of 100 among small companies in the same sector in 2025. Methodology
Against the sector
DIAGEN AS is 13 points below the median for small companies in the same sector in 2025.
Median score 50 among 36,110 companies.
Against small companies in the same sector in 2025: operating margin −4.6% (median 2.5%) and equity ratio 16.9% (median 38.3%).
The numbers behind the score
| Measure | Company | Median |
|---|---|---|
| Operating revenue | 17 MNOK | 3 MNOK |
| Operating margin | −4.6% | 2.5% |
| Profit margin | −5.5% | 2.2% |
| Return on assets | −1.4% | 4.0% |
| Equity ratio | 16.9% | 38.3% |
| Debt-to-equity | 4.91 | 0.99 |
| Current ratio | 1.32 | 1.70 |
| Revenue growth | 25.9% | 3.5% |
| Revenue per employee | 2.13 MNOK | 1.62 MNOK |
The median and “ahead of” refer to small companies in the same sector in 2025. The bar shows the share of companies the figure is ahead of.
With an index of 37, DIAGEN AS does better than 29% of small companies in the same sector (36,579 companies) in 2025.
Score 2023–2025
- DIAGEN AS
- Median: small companies in the same sector
DIAGEN AS has a score of 37 for 2025, rank 28,084 of 38,670 in the sector.
Strongest: Growth: percentile 79 against peers, revenue growth 25.9% against a median of 3.5%.
Weakest: Solidity: percentile 25 against peers, equity ratio 16.9% against a median of 38.3%. Profitability: percentile 29 against peers, operating margin −4.6% against a median of 2.5%.
Worth a closer look
- The company made a loss before tax. Are these one-off items or a pattern? Based on: profit margin −5.5% (median 2.2%).
- The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors? Based on: operating margin −4.6% (median 2.5%).
- What lies behind weak solidity, and will it last?
- What lies behind weak profitability, and will it last?
Written by fixed rules from the figures. Describes the figures, does not explain causes. Not investment or financial advice. How the summary is made
What the numbers say
DIAGEN AS had an operating margin of −4.6% and an equity ratio of 16.9% in 2025, and ranks 28,084 of 38,670 in Handel.
From 2024 to 2025: the operating margin rose from −26.6% to −4.6% and revenue grew by 26%.
This text is generated automatically from the 2025 accounts.
Three simple methods
One method gives a figure: 6 MNOK.
| Method | Multiple | Estimate |
|---|---|---|
| P/E | 10.0 | not meaningful |
| EV/EBIT | 8.0 | not meaningful |
| P/B | 1.0 | 6 MNOK |
A mechanical estimate from public accounts, not advice. Mechanical estimate from public accounts with fixed multiples. Not a valuation and not advice to buy or sell. The multiples are provisional default values and must be adjusted per sector before the figures are used for anything. See the calculation
Worth a closer look
- watch
The company made a loss before tax. Are these one-off items or a pattern?
Based on: Profit margin −5.5% (median 2.2%).
- watch
The operating margin is lower than at three in four companies in the sector. Where do costs differ from competitors?
Based on: Operating margin −4.6% (median 2.5%).
Indications based on the latest annual accounts from open data. Not investment or financial advice.
Financial costs were 1.2% of the debt in 2025. The policy rate averaged 4.30 % the same year. This is a plain description of what the debt cost, not a model of interest sensitivity.
Data quality
No anomalies found in the figures.
Scenario analysis: the sector's weakest year
We have no accounts for 2017, the sector's weakest year, for this company.
The sector's weakest year was 2017, with a median operating margin of −65.6%. Based on the 11 fiscal years we have. The analysis grows as more years are fetched or imported. Methodology
What the score is made of
| Profitability | 29 | weight 30% |
|---|---|---|
| Solidity | 25 | weight 25% |
| Liquidity | 39 | weight 15% |
| Growth | 79 | weight 15% |
| Consistency | 29 | weight 15% |
Durability: 43 (average over 3 years)
Index version 2. Data completeness 100%: the share of the weights that had data.
Questions and answers
How profitable is DIAGEN AS?
The operating margin was −4.6% in 2025, against a median of 2.5% among small companies in the same sector. Return on assets was −1.4%. The company made a loss before tax.
How solid is DIAGEN AS?
The equity ratio was 16.9% in 2025 (median 38.3%). Debt-to-equity was 4.91 (median 0.99).
What is the liquidity of DIAGEN AS like?
The current ratio was 1.32 in 2025 (median 1.70).
How does DIAGEN AS compare in Handel?
DIAGEN AS ranks 28,084 of 38,670 in Handel for 2025. Among companies of the same size (small companies) it ranks 26,081 of 36,579. Revenue changed by 25.9% from the year before.
Public contracts
- Contracts awarded since 2024
- 0
- Total awarded value since 2024
- value not stated
| Date | Buyer | Notice | Value |
|---|---|---|---|
| 21 November 2019 | SYKEHUSINNKJØP HF | VirClia til St. Olavs hospital | value not stated |
| 26 March 2018 | Sykehusinnkjøp HF | Reagenser og forbruksvarer til GeneXpert til Avd for mikrobiologi | value not stated |
Based on notices in Doffin. Does not show call-offs under framework agreements or purchases below the publication threshold. Values are as stated by the buyer.
Source: Doffin (DFØ), fetched 28 October 2026. Winners are matched on organisation number.
Contains data under the Norwegian licence for public data (NLOD 2.0) made available by Doffin/the Norwegian Agency for Public and Financial Management (DFØ). NLOD 2.0
From the Central Coordinating Register
- Org. no.
- 987520590
- Legal form
- AS
- Sector
- Handel (46.460)
- Size tier
- small
- Employees
- 8 registered 10 October 2026
- Founded
- 1 September 2004 22 years in operation
- Share capital
- 0.10 MNOK
- Business address
- Mosseveien 60, 1640 RÅDE
- Municipality
- Råde rank 4–13 of 40 in KOSTRA group 1
- Latest accounts filed
- 2025
- Website
- www.diagen.no
Source: Central Coordinating Register, Brønnøysund Register Centre. The employee count is reported by the company and may be older than the accounts. See the company at the Brønnøysund Register Centre
Ownership and roles
- Chief executive
- Vidar Lindberg
- Chair of the board
- Vidar Lindberg
- Deputy member
- Vegard Kjærheim
- Auditor
- BDO AS
- Accountant
- ABACUS RATIO AS
Source: Central Coordinating Register, fetched 29 October 2026. Only names are shown.
Owners and shareholdings will appear here once the shareholder data extract is in place.
Coming · not built yet
Error in the data?
Do you see an error in the figures or in how the company is mapped (sector, holding, group)? Let us know. Corrections require documentation.
Figures last fetched 29 October 2026.
Year by year · 2023–2025
| Key figure | 2023 | 2024 | 2025 | Trend |
|---|---|---|---|---|
| Index | 54 | 39 | 37 | |
| Rank | 15,114 | 25,714 | 28,084 | |
| Operating margin | −95.3% | −26.6% | −4.6% | |
| Return on assets | 35.3% | −11.9% | −1.4% | |
| Equity ratio | 31.8% | 27.6% | 16.9% | |
| Current ratio | 5.12 | 1.39 | 1.32 | |
| Revenue growth | – | 63.0% | 25.9% |
Accounts
From the Brønnøysund Register Centre, in the company's reporting currency (NOK).
| Key figure | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating revenue | 8.3 MNOK | 13.5 MNOK | 17.0 MNOK |
| Operating profit | −7.9 MNOK | −3.6 MNOK | −0.8 MNOK |
| Profit before tax | 14.6 MNOK | −8.0 MNOK | −0.9 MNOK |
| Net profit | 14.6 MNOK | −8.0 MNOK | −0.9 MNOK |
| Financial expenses | 1.5 MNOK | 4.8 MNOK | 0.4 MNOK |
| Total assets | 45.8 MNOK | 26.2 MNOK | 38.1 MNOK |
| Current assets | 43.8 MNOK | 13.6 MNOK | 10.4 MNOK |
| Equity | 14.6 MNOK | 7.2 MNOK | 6.5 MNOK |
| Retained earnings | 14.5 MNOK | 7.1 MNOK | 6.4 MNOK |
| Total liabilities | 31.3 MNOK | 19.0 MNOK | 31.7 MNOK |
| Current liabilities | 8.5 MNOK | 9.8 MNOK | 7.9 MNOK |
Source: Brønnøysund Register Centre (Register of Company Accounts), fetched 29 October 2026, accounts id 7097793.
Further
Similar companies
- DRAMMEN HELSEKOST AS index 37, rank 28,080 · compare
- SILENTIFIC AS index 37, rank 28,081 · compare
- SMAK AS index 37, rank 28,082 · compare
- BÆREKRAFT OG INNSATS FOR ANDRE AS index 37, rank 28,083 · compare
- SPECUP AS index 37, rank 28,085 · compare